Octagon Capital Advisors »

Dianthus Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.8M 554k 10.40
2023-09-30 $6.6M 480k 13.67